12885_2020_7447_MOESM1_ESM.docx (129.61 kB)
Download fileAdditional file 1 of Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study
journal contribution
posted on 2020-09-30, 03:59 authored by Di Ma, Juan Wang, Lu Liu, Meiqi Chen, Zhiyong WangAdditional file 1: Supplemental Figure 1. Full image of western blotting bands for p53 and its internal control actin shown in Fig. 7f. Membrane was pre-cut according to the molecular weight of p53 and Bax. After p53 (or Bax) staining, the membrane was stripped with stripping buffer and reprobed with the actin antibody (or Bcl-2). Note that the remanant obscure p53 band was seen right above the actin band.
Funding
Shanghai Science and Technology Committee
History
References
- 10.3322/caac.21492
- 10.1038/nrdp.2016.18
- 10.1016/j.currproblcancer.2017.10.007
- 10.3748/wjg.v25.i25.3151
- 10.1016/j.jhepr.2019.02.003
- 10.1053/j.semdp.2016.12.011
- 10.1056/NEJMoa1915745
- 10.1016/S0031-9422(00)89802-7
- 10.1021/jf0100604
- 10.1039/c3ob42503g
- 10.1016/j.redox.2018.02.015
- 10.1038/s41598-018-35083-2
- 10.1007/s10637-018-0698-2
- 10.1016/j.cell.2011.02.013
- 10.1373/clinchem.2008.105189
- 10.18632/oncotarget.24947
- 10.1160/TH12-11-0791
- 10.1016/S1470-2045(08)70285-7
- 10.1056/NEJMoa0708857
- 10.3748/wjg.v21.i13.3843
- 10.1016/j.fct.2012.05.033
- 10.1002/ijc.31378
- 10.1002/tox.22089
- 10.1021/acs.jafc.7b04650
- 10.1016/S0024-3205(99)00263-5
- 10.1055/s-0029-1185796
- 10.1016/j.jep.2016.04.049
- 10.1093/clinchem/48.8.1198
